These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34125501)

  • 21. Intestinal transplantation in children: the first successful Italian series.
    Colledan M; Stroppa P; Bravi M; Casotti V; Lucianetti A; Pinelli D; Zambelli M; Guizzetti M; Corno V; Aluffi A; Sonzogni V; Sonzogni A; D'Antiga L; Codazzi D
    Transplant Proc; 2010 May; 42(4):1251-2. PubMed ID: 20534273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe Late-Onset Acute Cellular Rejection in a Pediatric Patient With Isolated Small Intestinal Transplant Rescued With Aggressive Immunosuppressive Approach: A Case Report.
    Narang A; Xi D; Mitsinikos T; Genyk Y; Thomas D; Kohli R; Lin CH; Soufi N; Warren M; Merritt R; Yanni G
    Transplant Proc; 2019 Nov; 51(9):3181-3185. PubMed ID: 31711586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of graft-versus-host disease after intestinal transplantation.
    Ganoza A; Mazariegos GV; Khanna A
    Curr Opin Organ Transplant; 2019 Apr; 24(2):199-206. PubMed ID: 30762668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal transplantation: evolution in immunosuppression protocols.
    Pirenne J; Kawai M
    Curr Opin Organ Transplant; 2009 Jun; 14(3):250-5. PubMed ID: 19373085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation.
    Abu-Elmagd KM; Costa G; Bond GJ; Soltys K; Martin L; Koritsky DA; Cunha-Melo JR; Sogawa H; Irish W; Tzakis A; Mazariegos G
    Clin Transpl; 2012; ():155-66. PubMed ID: 23721018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes in children with intestinal failure following listing for intestinal transplant.
    Lao OB; Healey PJ; Perkins JD; Reyes JD; Goldin AB
    J Pediatr Surg; 2010 Jan; 45(1):100-7; discussion 107. PubMed ID: 20105588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful term pregnancy in an intestine-pancreas transplant recipient with chronic graft dysfunction and parenteral nutrition dependence: a case report.
    Marcus EA; Wozniak LJ; Venick RS; Ponthieux SM; Cheng EY; Farmer DG
    Transplant Proc; 2015 Apr; 47(3):863-7. PubMed ID: 25724255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Composite liver--small bowel allografts with preservation of donor duodenum and hepatic biliary system in children.
    Bueno J; Abu-Elmagd K; Mazariegos G; Madariaga J; Fung J; Reyes J
    J Pediatr Surg; 2000 Feb; 35(2):291-5; discussion 295-6. PubMed ID: 10693683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Alemtuzumab Induction With a Significantly Lower Incidence of GVHD Following Intestinal Transplantation: Results of 445 Consecutive Cases From a Single Center.
    Vianna R; Farag A; Gaynor JJ; Selvaggi G; Tekin A; Garcia J; Pierce C; Beduschi T
    Transplantation; 2020 Oct; 104(10):2179-2188. PubMed ID: 31929428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft-versus-host disease after liver and small bowel transplantation in a child.
    Reyes J; Todo S; Green M; Yunis E; Schoner D; Kocoshis S; Furukawa H; Abu-Elmagd K; Tzakis A; Bueno J; Starzl TE
    Clin Transplant; 1997 Oct; 11(5 Pt 1):345-8. PubMed ID: 9361921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestine and multivisceral transplantation: current status and future directions.
    Kubal CA; Mangus RS; Tector AJ
    Curr Gastroenterol Rep; 2015 Jan; 17(1):427. PubMed ID: 25613179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor.
    Acquazzino MA; Fischer RT; Langnas A; Coulter DW
    Pediatr Transplant; 2013 Aug; 17(5):466-71. PubMed ID: 23730873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fifteen years' experience of intestinal and multivisceral transplantation in the Nordic countries.
    Varkey J; Simrén M; Jalanko H; Oltean M; Saalman R; Gudjonsdottir A; Gäbel M; Borg H; Edenholm M; Bentdal O; Husby S; Staun M; Mäkisalo H; Bosaeus I; Olausson M; Pakarinen M; Herlenius G
    Scand J Gastroenterol; 2015 Mar; 50(3):278-90. PubMed ID: 25592555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transplantation en masse of abdominal organs].
    Starzl T
    Ann Gastroenterol Hepatol (Paris); 1992; 28(1):39-43. PubMed ID: 1554235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of ultrashort bowel syndrome due to malrotation with midgut volvulus managed at an interdisciplinary pediatric intestinal rehabilitation center.
    Hong CR; Han SM; Staffa SJ; Carey AN; Modi BP; Jaksic T
    J Pediatr Surg; 2019 May; 54(5):964-967. PubMed ID: 30826119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary experience with intestinal transplantation in infants and children.
    Langnas AN; Shaw BW; Antonson DL; Kaufman SS; Mack DR; Heffron TG; Fox IJ; Vanderhoof JA
    Pediatrics; 1996 Apr; 97(4):443-8. PubMed ID: 8632926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome after intestinal transplantation: results from one center's 9-year experience; discussion 1031-2.
    Farmer DG; McDiarmid SV; Yersiz H; Cortina G; Amersi F; Vargas J; Gershman G; Ament M; Busuttil RW
    Arch Surg; 2001 Sep; 136(9):1027-31. PubMed ID: 11529825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental short-term immunosuppression after bowel transplantation and donor-specific bone marrow infusion.
    Harmon JV; Gruessner AC; Nakhleh RE; Zhang K; Gruessner RW
    Arch Surg; 2001 Jul; 136(7):817-21. PubMed ID: 11448397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Portal donor-specific blood transfusion and mycophenolate mofetil allow steroid avoidance and tacrolimus dose reduction with sustained levels of chimerism in a pig model of intestinal transplantation.
    Gruessner RW; Levay-Young BK; Nakhleh RE; Shearer JD; Dunning M; Nelson CM; Gruessner AC
    Transplantation; 2004 May; 77(10):1500-6. PubMed ID: 15239611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.